Answers are grounded in this paper and cite their sources.
We, therefore, suggest that proTα, and likely proTα(100-109), act as alarmins, being important immune mediators as well as biomarkers, and could eventually become targets for new therapeutic/diagnostic approaches in immune-related diseases like cancer, inflammation, and sepsis.
No takes yet. Share an insight, caveat, or question.
Samara et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: